9/19
07:58 am
atha
Athira Pharma, Inc. (NASDAQ: ATHA) was downgraded by analysts at Mizuho from an "outperform" rating to a "neutral" rating. They now have a $0.50 price target on the stock, down previously from $5.00.
Low
Report
Athira Pharma, Inc. (NASDAQ: ATHA) was downgraded by analysts at Mizuho from an "outperform" rating to a "neutral" rating. They now have a $0.50 price target on the stock, down previously from $5.00.
9/19
07:58 am
atha
Athira Pharma, Inc. (NASDAQ: ATHA) was downgraded by analysts at Mizuho from an "outperform" rating to a "neutral" rating. They now have a $0.50 price target on the stock, down previously from $5.00.
Low
Report
Athira Pharma, Inc. (NASDAQ: ATHA) was downgraded by analysts at Mizuho from an "outperform" rating to a "neutral" rating. They now have a $0.50 price target on the stock, down previously from $5.00.
9/19
06:50 am
atha
Rating for ATHA
Low
Report
Rating for ATHA
9/19
06:50 am
atha
Rating for ATHA
Low
Report
Rating for ATHA
9/4
12:11 pm
atha
Rating for ATHA
Medium
Report
Rating for ATHA
9/4
12:11 pm
atha
Rating for ATHA
Medium
Report
Rating for ATHA
9/4
10:35 am
atha
Rating for ATHA
Medium
Report
Rating for ATHA
9/4
08:37 am
atha
Athira Pharma, Inc. (NASDAQ: ATHA) was downgraded by analysts at Rodman & Renshaw from a "buy" rating to a "neutral" rating.
High
Report
Athira Pharma, Inc. (NASDAQ: ATHA) was downgraded by analysts at Rodman & Renshaw from a "buy" rating to a "neutral" rating.
9/4
08:37 am
atha
Athira Pharma, Inc. (NASDAQ: ATHA) was downgraded by analysts at Rodman & Renshaw from a "buy" rating to a "neutral" rating.
High
Report
Athira Pharma, Inc. (NASDAQ: ATHA) was downgraded by analysts at Rodman & Renshaw from a "buy" rating to a "neutral" rating.
9/4
07:38 am
atha
Athira Pharma, Inc. (NASDAQ: ATHA) was downgraded by analysts at BTIG Research from a "buy" rating to a "neutral" rating.
High
Report
Athira Pharma, Inc. (NASDAQ: ATHA) was downgraded by analysts at BTIG Research from a "buy" rating to a "neutral" rating.
9/4
07:38 am
atha
Athira Pharma, Inc. (NASDAQ: ATHA) was downgraded by analysts at JMP Securities from an "outperform" rating to a "market perform" rating.
High
Report
Athira Pharma, Inc. (NASDAQ: ATHA) was downgraded by analysts at JMP Securities from an "outperform" rating to a "market perform" rating.
9/4
07:38 am
atha
Athira Pharma, Inc. (NASDAQ: ATHA) was downgraded by analysts at JMP Securities from an "outperform" rating to a "market perform" rating.
High
Report
Athira Pharma, Inc. (NASDAQ: ATHA) was downgraded by analysts at JMP Securities from an "outperform" rating to a "market perform" rating.